Recognized expert in risk based quality management and compliance from 28 years in drug/vaccine development, quality oversight, and compliance roles. Current Vice President of Global Quality for Lykos Therapeutics, and faculty member of the Institute for Translational Medicine and Therapeutics directing the Quality Assurance program of study for the University of Pennsylvania. Fully engaged in quality system development strategies leveraging quality by design, critical thinking, open dialogue, continuous improvement and regulatory best practices through partnership and education across pharmaceutical, biotech, academia, and non-profit affiliations.